– Thumbs up Superior Pharma’s Products
A Consultant Urologist at the University of Nigeria Teaching Hospital (UNTH), Enugu, Dr Okwudili Calistus Amu has clarified the widespread myth that regular sexual activity can prevent or reduce the risk of prostate cancer, stating that there is no conclusive evidence linking sexual activities to a reduced risk of prostate cancer.
Dr Amu, who has over 17 years of experience in the field of urology, acknowledges that there are some evidences suggesting that frequent ejaculation may indeed have a beneficial effect on prostate health, but there are no concrete evidence connecting the frequency of sexual intercourse to reduction in the risk of developing prostate cancer.
In an exclusive interview with pharmanewsonline, he said “Studies have shown that frequent ejaculation may help improve blood flow and clear the prostate, potentially preventing issues like enlargement or inflammation,” he says. “In that sense, it could be a factor in maintaining good prostate health.”
However, Amu was quick to point out that there is no conclusive evidence linking regular sexual activity to a reduction in the risk of prostate cancer. “While frequent ejaculation might support general prostate health, it has not been scientifically proven to prevent or inhibit prostate cancer specifically,” he clarifies. “We cannot categorically say that regular sex is a protective factor against prostate cancer.”
He has also applauded the performance of two prostate health products from Superior Pharmaceuticals’ stable, as he expressed his satisfaction with these products at the recently concluded national conference of the Nigerian Association of Urological Surgeons (NAUS) in Enugu.
The Consultant Urologist, who has dedicated much of his career to diagnosing and treating prostate-related conditions, with expertise in areas like prostate enlargement, prostatitis, urinary tract infections (UTIs), and prostate cancer; gave invaluable insights on prostate health, the effectiveness of current treatments, and the truth behind common myths surrounding prostate enlargement and cancer.
Effective management of prostate enlargement
According to him, the management of these conditions involves a combination of medication and regular medical check-ups. “We use various medications for different prostate conditions,” he explains. “Some of the common drugs include Tamsulosin, Dutasteride, Bicalutamide, and Abiraterone, among others. These medications help manage symptoms and slow the progression of diseases like prostate enlargement and prostate cancer.”
One of the prominent pharmaceutical companies Dr Amu works with is Superior Pharmaceutical Products, known for its effective and affordable drugs. In particular, he highlighted Flowel (Tamsulosin) and Flowel Plus (Tamsulosin combined with Dutasteride) as excellent options for treating prostate conditions. “Many of our patients have reported positive results after using these products,” Dr. Amu shares. “In fact, some go ahead to purchase the medications on their own after seeing the benefits firsthand.”
Dr Amu’s collaboration with Superior Pharmaceutical Products has been ongoing, and he is optimistic about future partnerships. “They have been wonderful in terms of providing reliable and effective solutions for prostate health. I look forward to continuing our work together.”
Prostate health and early detection
Dr Amu also emphasised the importance of early detection and regular medical examinations for men, particularly those over the age of 50 or with a family history of prostate cancer. He noted that many prostate issues, including cancer, can remain asymptomatic in the early stages, which is why regular screening is crucial.
“Many men don’t experience symptoms in the early stages of prostate cancer or enlargement, which is why routine check-ups are so important,” he says. “Detecting prostate issues early can lead to more effective treatment and a better quality of life for the patient.”
While prostate cancer is one of the leading causes of cancer-related deaths in men, Amu is hopeful that continued advancements in medical technology and treatment options will improve patient outcomes. “With the right treatment and early intervention, many men with prostate cancer can live long and healthy lives,” he asserts.
The path forward in prostate health
Looking to the future, Dr Amu is optimistic about the potential for further advancements in urology and prostate health management. He hopes to continue his work with pharmaceutical companies to improve the quality of treatment available to his patients. Additionally, he stressed the importance of education and awareness in dispelling myths surrounding prostate health, urging men to seek professional advice rather than relying on unverified information.
Dr Okwudili Amu’s expertise provides valuable insights into the current state of prostate health and treatments, while also helping to clarify some of the common misconceptions surrounding prostate enlargement and cancer. As awareness grows and medical research continues, the path forward looks promising for those seeking better understanding and care for prostate conditions.
With early detection, appropriate treatment, and a proactive approach to health, men can manage prostate-related issues and lead healthier lives.
, Enugu, Dr Okwudili Calistus Amu has){kind=link}